Objective: It remains uncertain whether donor cause of brain death (DCBD) affects survival and freedom from bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). In addition, it is unknown whether the length of time interval from brain insult to brain death [BI-BD] and from brain death to cold preservation [BD-CP] has an impact on outcome. Methods: Medical charts of isolated lung transplant recipients from 400 consecutive donors were reviewed and classified according to DCBD: 190 vascular [V], 185 traumatic [T], 25 others [O]. Demographics were compared between donor groups. Hospital outcome, survival, and freedom from BOS in recipients were analyzed in relation to DCBD and related time intervals. Results: Donor age, gender, and weight differed between donor groups ( p < 0.001, p < 0.001, p < 0.05; respectively). No differences in recipient hospital outcome, survival, and freedom from BOS were found between groups. [BD-CP] longer than 10 h resulted in a survival advantage (69% vs 58% and 51% vs 42% at 5 and 10 years, respectively; p < 0.05) and a reduced hazard risk (0.952) of dying after LTx; ( p < 0.05). Multivariable analysis failed to show a significant correlation between DCBD and [BI-BD] versus survival and BOS. Conclusion: DCBD and [BI-BD] do not affect survival and freedom from BOS after LTx. Lung recipients from donors certified brain dead with a time interval longer than 10 h prior to organ preservation showed improved survival unrelated to BOS. This may result from longer and better donor management with reduced lung injury. #
Introduction
Lung transplantation (LTx) is an effective treatment modality for selected patients suffering from any form of end-stage pulmonary disease [1] . Since the first reports of successful isolated LTx by the Toronto Lung Transplant Group in 1986, this form of surgical treatment has evolved significantly with better early and late survival rates. The main limiting factor, however, remains the scarcity of suitable lung donors with only 10-20% of multi-organ donors matching the ideal lung criteria. As a result, many transplant teams worldwide have now turned to the use of extended criteria donors [2] , including donors after cardiac death [3] .
In the year 2008, only 16 out of 972 (1.6%) pulmonary transplants were performed with lungs recovered from donors after cardiac death in Eurotransplant [4] . At present, brain-dead donors continue to be the major donor source for LTx. It has been known for many years that the process of brain (stem) death may have detrimental effects on the potential organ donor. This results from hemodynamic, hormonal, and inflammatory changes that follow the catecholamine storm after an explosive rise in intracranial pressure [5, 6] . The lung is specifically vulnerable to injury after brain death. Hemodynamic alterations following the socalled Cushing reflex will increase left atrial and pulmonary capillary hydrostatic pressures. Inflammatory stimuli lead to increased pulmonary endothelial permeability. Hormonal changes will diminish alveolar fluid clearance. All this may result in neurogenic lung edema, making many pulmonary grafts no longer suitable for transplantation [7, 8] .
Different donor causes of brain death (DCBD) have been shown to affect outcome in renal [9] , and possibly also in heart transplantation [10] . The impact of DCBD on the outcome after LTx has been less investigated. In none of previously published studies [11] [12] [13] was a strong correlation found between the mode of death in the donor and early and late survival in the recipient after LTx. To the best of our knowledge, no studies have previously investigated the possible impact on outcome after LTx related to the time intervals elapsed from brain insult to brain death [BI-BD] and from brain death to cold preservation [BD-CP]. The length of both intervals may well be a determinant of outcome, with the first interval reflecting the explosiveness and subsequent pathophysiological changes during the agonal phase until brain death and the second interval reflecting the time during which lung injury can develop and regress as a result of appropriate donor treatment.
This review of our lung transplant cohort was performed to determine whether there was an association between DCBD and clinical outcome after LTx, including survival and freedom from bronchiolitis obliterans syndrome (BOS). Second, we were interested to know whether the time intervals [BI-BD] and [BD-CP] had an impact on survival and freedom from BOS after LTx.
Patients and methods

Study design
All consecutive, isolated, lung transplant procedures (n = 401) performed at the University Hospitals Leuven between July 1991 and August 2008 were reviewed. Heart-lung recipients (n = 40) as well as lung recipients from non-brain-dead donors (n = 5) were excluded from the study. Donors and recipients were matched for blood group and total lung capacity, as predicted, based on height and gender. A total of 143 single LTx (SLTx) (71 left-sided and 72 right-sided) and 258 bilateral LTx (SSLTx) were performed.
Informed consent was obtained from the recipients according to the Belgian law on patients' rights regarding data registration. Approval for analyzing recorded data was waived by the institutional ethics committee on human research given the retrospective nature of the study.
Donor data
Both lungs from one donor were transplanted in twin recipients at our center. Medical charts of these 400 consecutive donors were reviewed and classified according to their DCBD into vascular [V] (stroke or spontaneous bleeding): n = 190, traumatic [T]: n = 185, and other brain insults [O] : n = 25 including hypoxia (n = 18), metabolic disorders (n = 4), tumor (n = 2), and infection (n = 1). Donor demographics (age, gender, weight, height, and body mass index (BMI)) and other variables (cytomegalovirus (CMV) status, partial arterial oxygen tension (PaO 2 ) over inspired oxygen fraction (FiO 2 ) of 1.0, and the time intervals [BI-BD] and [BD-CP]) were compared between the three donor groups.
Recipient data
Recipient data were retrieved from our prospective transplant database. Follow-up was complete in all patients with a median of 30 months (0-202 months). Indications for LTx were emphysema (n = 193), pulmonary fibrosis (n = 75), cystic fibrosis (n = 60), pulmonary hypertension (n = 13), and miscellaneous (n = 60). SLTx was performed in 86 male and 57 female patients and SSLTx in 143 male and 115 female patients (N.S.). Recipient demographics (age, gender, weight, height, and BMI) and other characteristics such as CMV status, recipient diagnosis, and allograft type were compared in relation to the three donor groups.
Outcome
Ischemic times, PaO 2 /FiO 2 at 0 (T0), 12 (T12), 24 (T24), and 48 (T48) h after LTx, time to extubation, intensive care unit (ICU) stay and hospital stay, survival, and freedom from BOS were compared between the three donor groups. BOS was diagnosed by a progressive and irreversible decline in forced expiratory volume in 1 s (FEV1) as defined by the International Society for Heart and Lung Transplantation [1] .
Statistical analysis
All baseline characteristics for donors and recipients are summarized by DCBD. Categorical data are presented as frequencies (percentages). Statistical comparisons between groups were performed using a chi-square test. Continuous variables are presented as mean AE standard deviation (normal distribution) or median + interquartile range (IQR) (no Gaussian distribution). The former were analyzed by means of analysis of variance (ANOVA), whereas the latter were compared by means of a Kruskal-Wallis test. Comparisons between groups for height and weight were adjusted for gender.
Two outcomes were of specific interest: overall survival and freedom from BOS. For the first end point, Kaplan-Meier survival curves were estimated according to DCBD, [ [14] . Deviations from these assumptions were remedied by including higher order terms and time-dependent covariates, respectively. Results are expressed as hazard ratios (HRs), their 95% confidence intervals, and associated p values.
All statistical analyses were done using SAS v9.2 or 9.1 (Kaplan-Meier curves). Statistical significance was assessed at the 5% significance level.
Results
Donors
Donor characteristics classified according to DCBD are presented in Table 1 
Recipients
Recipient characteristics grouped by DCBD are presented in Table 2 . Significant differences were found for gender, weight, and height, but not age. There were no significant differences according to donor groups with respect to recipient BMI, CMV status, diagnosis, and allograft type.
Hospital outcome
Four patients have died intra-operatively from uncontrollable bleeding; hence, no further outcome data were available for analysis. No significant differences were seen between recipients according to donor groups as regards ischemic times, days until extubation, ICU stay, hospital stay, and oxygenation (PaO 2 /FiO 2 ) after transplantation ( Table 2) .
No differences in hospital mortality (n = 27 or 7%) were seen between the three donor groups ([T]: n = 13, [V]: n = 12, [O]: n = 2; p = 0.932).
Survival
No statistically significant differences in recipient survival were identified between the three donor groups (log-rank p = 0.579). Estimates of survival at 1, 5, and 10 years after LTx are presented in Fig. 2(B) ).
The results from the Cox regression analyses for the independent association between DCBD, [BI-BD], and 
Freedom from BOS
A total of 84 BOS events were observed throughout the entire follow-up period. The cumulative freedom from BOS stratified by DCBD is presented in Fig. 3 . Pair-wise comparisons in freedom from BOS between the groups revealed no statistical difference.
The cumulative incidence curves for the freedom from BOS Table 4 . No associations could be identified for any of the variables.
Discussion
The present study failed to show an association between DCBD and outcome (survival and freedom from BOS). In addition, the time interval [BI-BD] did not affect the outcome. We did, however, find an association between the time interval [BD-CP] and survival. Recipients from [ ( ) T D $ F I G ] donors with an interval longer than 10 h between certification of brain death and organ retrieval experienced an improved survival. Our findings are in accordance with the results from previously published studies exploring DCBD [11] [12] [13] . Waller et al. in 1995 were the first to investigate the influence of the mode of donor death on outcome in LTx [11] . These authors compared the use of traumatic (n = 57) versus non-traumatic donors (n = 66) and concluded that the use of donors involved in major trauma does not increase the risk of early complications after LTx. Another study from the Washington University lung transplant group at St Louis published in 2002 also did not find a difference in hospital outcome or in early survival between traumatic (n = 295) versus non-traumatic (n = 205) brain injury donor groups [12] . Finally, in 2004, Ganesh et al. published the results from a national prospective cohort study in the U.K. including 580 transplants [13] . Donors were classified into vascular (n = 372), traumatic (n = 153), hypoxic (n = 38), and infectious (n = 17) brain damage. This largest series so far also failed to identify a relationship between DCBD and post-transplant survival up to 5 years. Singhal et al. studied the impact of DCBD on transplant outcomes based on data from the United Network for Organ sharing (UNOS) registry with more than 86 000 donors between 1989 and 2008 [15] . In a univariate analysis, stroke as DCBD was associated with worse graft survival across all organs with a relative risk of 1.22 (1.17-1.28) for lung recipients from these donors. Lung recipients from anoxic donors showed improved survival (relative risk (RR) = 0.89). After adjustment in a multivariate analysis, modest differences persisted in survival of heart, kidney, and liver, but not lung allograft recipients. Anoxia as DCBD was associated with significantly less rejection relative to donor death caused by head trauma and stroke.
To the best of our knowledge, our study is the first that looked into the time intervals [BI-BD] and [BD-CP] in relation to survival and freedom from BOS after LTx. No impact on outcome could be found from the length of time between the moment of brain insult till diagnosis of brain death. This time interval reflects somehow the agonal phase in the donor that follows the sudden increase in intracranial pressure. One would expect that the shorter this interval was, the more explosive the brain injury and thus the catecholamine storm and subsequent pathophysiological changes were, ultimately leading to lung injury. Recipients from donors with such an interval 48 h did not have worse early outcome. Interestingly, we have found that the length of time between the diagnosis of brain death and the moment of organ retrieval did affect the survival with more ( p < 0.05) recipients alive at 5 and 10 years transplanted with lungs from donors with such an interval that was longer than 10 h. Further, on multivariate analysis, a statistically significant association ( p < 0.05) between [BD-CP] and survival was found. This suggests that for every hour increase in [BD-CP] the hazard of dying in the years after the transplant procedure is reduced by 5%. The exact reason for this difference in survival is not clear from our study. The quality of the donor lung may well improve as the lung recovers from brain-death-related injury with a longer time interval elapsed between the moment of sympathetic discharge in the brain-dead donor and cold perfusion. However, no differences in PaO 2 /FiO 2 levels in the donors were seen when stratified between both time intervals (482 mmHg vs 477 mmHg for [BD-CP] 10 h vs > 10 h, respectively). Further, the survival difference was not seen in the first year after transplantation, but only at a later stage, suggesting that this survival benefit was not related to better early graft function, but rather to other factors. It is well known that the allograft type plays a significant role in survival after LTx. Single-lung recipients have a worse survival rate and freedom from BOS compared with double-lung patients [16] . We have seen similar survival differences in our transplant cohort (data not shown). The allograft type as known covariate was therefore included in the Cox regression analysis for survival and freedom from BOS. Survival advantage for lung recipients from [BD-CP] > 10 h remained significant. The fact that the difference was not found for freedom from BOS suggests that the survival difference was not related to less chronic rejection in recipients from lung donors with [BD-CP] > 10 h. The reasons for this difference in survival, therefore, remain unclear. We can only speculate that a longer and better management of hemodynamic instability, improved ventilatory settings, and anti-inflammatory and hormonal treatment may have reduced neurogenic edema and inflammation in the lung graft. However, we have no data regarding blood pressure or catecholamine levels over time, and no insight in the management of our donors in this study to support this hypothesis. In a study by Kaneda et al., messenger RNA (mRNA) levels of the cytokines interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-alpha and IL-1 beta measured in lung biopsies were found to be risk factors for early mortality, while IL-10 and interferon (IFN)-gamma were protective factors [17] . It would be interesting to measure these cytokine levels in bronchioloalveolar lavage fluid in donor lungs at different intervals after brain death in a prospective cohort of donors to see the differences over time elapsed from brain insult until organ recovery and the relation with survival.
In an experimental study in rats, Avlonitis et al. could demonstrate that lungs retrieved from untreated donors 15 min after brain death developed more graft injury upon reperfusion as a result of higher pulmonary vascular resistance when compared with a group with lungs retrieved 5 h after brain death, despite similar levels of inflammatory markers [18] . The authors concluded that delaying retrieval may allow the lung to recover from the hemodynamic injury. In another rat study by the group from Groningen, the relationship was investigated between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys [19] . The duration of brain injury was also investigated in a study by Odim et al. after pediatric heart transplantation [20] . The authors concluded that longer durations of brain injury and brain death intervals before donor-organ recovery and engraftment correlated with improved freedom from rejection, but had no effect on mortality after pediatric heart transplantation. In another clinical study by Kunzendorf et al., the duration of donor brain death on graft function after kidney transplantation was investigated [21] . Kidney grafts harvested from donors with longer duration of brain death (>470 min) exhibited a significantly higher incidence of primary graft function and a significantly better graft survival in comparison to kidneys from donors with a shorter duration of brain death. More studies are needed to further investigate the impact of the time elapsed between brain death and organ retrieval on outcome after LTx.
No association could be found between DCBD, [BI-BD], and [BD-CP], and their combined effect with freedom from BOS. Our results are in contrast with the report by Ciccone et al., who found that recipients from traumatic brain injury donors had a higher risk to develop BOS at 5 years (65.5%) when compared with non-traumatic donor recipients (49.2%) [12] . Traumatic recipients also showed a higher severity and frequency of rejection episodes during the first year after transplantation. These findings, however, were not seen in a large national cohort study in the U.K. [13] . The impact of DCBD on the development of BOS, therefore, remains unclear. Studies in rats have demonstrated that donor brain death increases expression of IL-2 mRNA and aggravates chronic rejection after lung transplantation when compared with living donors [22] . Various allogenic and non-allogenic factors have been identified with an increased risk for development of BOS, such as acute rejection episodes, human leukocyte antigen (HLA) mismatching, CMV and other viral infections, airway ischemia, donor age, ischemic time, type of transplant, and gastric aspiration [23, 24] . By correcting for some of these risk factors in our Cox regression The present study suffers from several limitations. First, this is a retrospective study including data collected over a long time period (from 1991 to 2008). Our donor acceptance criteria, lung preservation protocol and methods, and recipient management have undergone significant changes over time with more experience accrued [25] . We can only speculate that these changes were equally distributed among the three donor groups. Second, a few data on recipient oxygenation in the first hours after transplantation were missing in the charts of our very first patients. However, statistical analysis accounted for missing data. Third, the follow-up in the recipients transplanted over the past years may be too short to identify the onset of BOS. Furthermore, the time intervals [BI-BD] and [BD-CP] are estimates as only the time of hospital admission was recorded, but the brain insult itself may have started some hours earlier. Further, the moment of brain death is not always known exactly as diagnosis is based on a thorough neurological examination or brain tests. These investigations may not have been performed until some hours later. In addition, we had no insight into the quality of donor management before and after brain death. This may well vary between different donor hospitals. We can only speculate that these variations were equally distributed among the three donor groups. Finally, the positive effect on survival from a longer interval [BD-CP] must be interpreted with caution and confirmed by other groups, as it is always possible that our finding results from an artifact in the data related to a hidden confounder.
In conclusion, we did not find an association between donor cause of brain death as well as the length of the interval from brain injury to brain death and survival or freedom from BOS. Recipients from brain-dead donors with an interval longer than 10 h prior to lung preservation had a superior survival unrelated to BOS. This may well be the result of a longer and better donor management with reduced lung injury before organ retrieval. 
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Recipient age (NPH) For donor cause of brain death, the reference category for the hazard ratios is the category trauma. The model includes second and third order polynomial order terms for ICU stay and time-varying covariates to allow for non-proportional hazards (NPH) for age. BOS, bronchiolitis obliterans syndrome; PaO
